Ms. Rebecca N Morgan, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 155 Church St, Holliston, MA 01746 Phone: 508-429-8032 Fax: 508-429-8031 |
Holly Fischer-engel, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 229 Underwood St, Holliston, MA 01746 Phone: 617-512-2270 |
Ms. Nicole Kindler, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 368 Ashland St, Holliston, MA 01746 Phone: 978-267-1851 |
Carrie Elene Peterson, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 89 Winthrop St, Holliston, MA 01746 Phone: 612-803-8400 |
Ms. Lindsey Brett Forman, MSW, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 100 Jeffrey Ave, Holliston, MA 01746 Phone: 508-429-2800 |
Ms. Ellen S. Bettmann Piontek, M.ED. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 170 Mellen St, Holliston, MA 01746 Phone: 508-429-6125 Fax: 508-429-9204 |
Ms. Marilyn Brine Gilmour, MSW, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 200 Winter St, Holliston, MA 01746 Phone: 508-893-0914 Fax: 508-429-9657 |
Mrs. Julie Dicicco, LICSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 27 Charles St Ste 1, Holliston, MA 01746 Phone: 774-233-0108 |
Mrs. Gail M. Conley, L.I.C.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 838 Washington St, Holliston, MA 01746 Phone: 508-429-5558 |
Ms. Simone Tetrault, L.I.C.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 448 Marshall St, Holliston, MA 01746 Phone: 617-610-0137 |
Ms. Linda Gail Arkow, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21 Carlton Drive, Holliston, MA 01746 Phone: 508-429-7501 Fax: 508-429-7501 |
Mrs. Gretchen Hazen Powers, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 118 Washington St, Holliston, MA 01746 Phone: 508-207-5495 Fax: 508-429-6353 |
News Archive
Fate Therapeutics, Inc. announced today that the Company was named as one of Technology Review's 2010 TR50, the publication's first annual list of the 50 most innovative companies in the world. The 2010 TR50 companies span the fields of energy, computing, the Web, biomedicine, and materials and have been evaluated based on business model, strategies for deploying and scaling up its technologies and the likelihood of success. Each company in the 2010 TR50 has excelled not only at inventing technology but also at using it to transform how we live and work.
New York Blood Center and its divisions serving the 20 million people of New York City, Long Island, the Hudson Valley, and New Jersey call upon the community to please donate blood, in recognition of World Health Day, and to help save lives.
Americans for Nonsmokers' Rights (ANR), a national public health advocacy organization, filed complaints on May 20th with the New York Consumer Protection Board and the New York Attorney General's Office, claiming that two air filtration companies, FailSafe Air Safety Systems (http://www.fasscorp.com) and Airistar Technologies, LLC (http://www.airistar.net) are engaging in false advertising by misrepresenting the ability of their products to reduce health risks caused by secondhand tobacco smoke.
GENova Biotherapeutics Inc. ("GENova"), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced it has signed an engagement agreement with PacificWave Partners Limited ("PacWave") for raising a minimum of USD5m to the company as well as actively look for potential buy-out and/or acquisition targets.
Controlled release pills and capsules that show a tendency in the standard laboratory test toward "dose dumping" - releasing their medicine in a faster and potentially unsafe manner in patients who have consumed alcohol - should be withheld from the market until proven safe with testing in people. That's the conclusion of a review of existing studies in the September-October issue of ACS' Molecular Pharmaceutics, a bi-monthly journal.
› Verified 6 days ago